Roivant Sciences Ltd.
ROIV | NASDAQ
$38.92
-$0.85 (-2.14%)
Sep 21, 2026, 11:52 AM ET · Market open
TTM Period Ending | Q1 2026 Jun 29, 2026 | Q4 2025 Mar 30, 2026 | Q3 2025 Dec 30, 2025 | Q2 2025 Sep 29, 2025 | Q1 2025 Jun 29, 2025 | Q4 2024 Mar 30, 2025 | Q3 2024 Dec 30, 2024 | Q2 2024 Sep 16, 2024 | Q1 2024 Jun 29, 2024 | Q4 2023 Mar 30, 2024 | Q3 2023 Dec 30, 2023 | Q2 2023 Sep 29, 2023 | Q1 2023 Jun 29, 2023 | Q4 2022 Mar 30, 2023 | Q3 2022 Dec 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 7.53M | 8.26M | 13.31M | 20.33M | 23.23M | 29.05M | 50.41M | 56.96M | 56.13M | 69.76M | 68.21M | 69.7M | 66.05M | 44.43M | 17.05M |
Cost of Revenue | 1.42M | 1.29M | 1.17M | 729K | 852K | 911K | 5.12M | 5.06M | 5.05M | 9.05M | 14.02M | 22.15M | 21.92M | 17.71M | 8.32M |
Gross Profit | 6.12M | 6.98M | 12.14M | 19.6M | 22.38M | 28.14M | 45.3M | 51.9M | 51.09M | 60.72M | 54.19M | 47.55M | 44.13M | 26.72M | 8.73M |
Operating Income | -1.37B | -1.29B | -1.22B | -1.15B | -1.19B | -1B | -984.33M | 4.42B | 4.55B | 4.37B | 4.4B | -1B | -790.91M | -514.49M | -280.33M |
Interest Income | 166.71M | 178.11M | 191.55M | 210.14M | 234.57M | 258.38M | 287.21M | 257.31M | 201.84M | 146.43M | 77.25M | 55.55M | 41.25M | 24.53M | 10.25M |
Pretax Income | -289.88M | -264.58M | -921.73M | -865.87M | -931.21M | -681.59M | -669.99M | 4.72B | 4.7B | 4.39B | 4.41B | -1.13B | -887.39M | -561.29M | -382.08M |
Net Income | -266.25M | -299.77M | -809.24M | -373.97M | -490.63M | -171.98M | -116.62M | 4.81B | 4.74B | 4.35B | 4.47B | -981.77M | -677.45M | -385.63M | -352.01M |
Selling & General & Admin | 641.97M | 610.47M | 599.31M | 565.78M | 625.54M | 591.41M | 613.93M | 600.56M | 486.26M | 542.55M | 493.24M | 528.59M | 440.01M | 283.82M | 163.52M |
Research & Development | 730.91M | 681.81M | 628.11M | 604.32M | 582.83M | 550.41M | 526.08M | 492.63M | 464.35M | 468.97M | 479.93M | 497.31M | 382.52M | 257.39M | 125.53M |
Other Expenses | -392K | n/a | n/a | n/a | n/a | -110.39M | -110.39M | -5.46B | -5.44B | -5.32B | -5.32B | 26.45M | 12.5M | n/a | n/a |
Operating Expenses | 1.37B | 1.29B | 1.23B | 1.17B | 1.21B | 1.03B | 1.03B | -4.37B | -4.49B | -4.31B | -4.35B | 1.05B | 835.04M | 541.21M | 289.06M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 13.4M | 13.4M | 22.84M | 32.09M | 27.6M | 36.18M | 35.18M | 25.93M | 17.02M | 8.45M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.37B | 1.29B | 1.23B | 1.17B | 1.21B | 1.03B | 1.03B | -4.36B | -4.49B | -4.3B | -4.33B | 1.07B | 856.96M | 558.92M | 297.38M |
Income Tax Expense | 124.72M | 133.33M | 84.3M | 35.4M | 40.86M | 48.17M | -10.1M | 37.83M | 28.61M | 18.4M | 23.56M | 4.01M | 778K | -974K | 2.82M |
Shares Outstanding (Basic) | 720.78M | 702.13M | 696.86M | 680.95M | 680.29M | 707.3M | 722.72M | 735.47M | 735.82M | 802.86M | 800.59M | 770.23M | 759.27M | 742.54M | 713.32M |
Shares Outstanding (Diluted) | 720.78M | 812.29M | 696.86M | 680.95M | 680.29M | 707.3M | 722.72M | 735.47M | 781.63M | 802.86M | 844.46M | 770.23M | 759.27M | 742.54M | 713.32M |
EPS (Basic) | -0.38 | -0.45 | -1.17 | -0.56 | -0.70 | -0.24 | -0.14 | 6 | 5.91 | 5.40 | 5.54 | -1.32 | -0.92 | -0.54 | -0.49 |
EPS (Diluted) | -0.44 | -0.51 | -1.17 | -0.56 | -0.70 | -0.25 | -0.15 | 5.65 | 5.56 | 5.06 | 5.20 | -1.32 | -0.92 | -0.54 | -0.49 |
EBITDA | -281.34M | -261.23M | -917.59M | -859.51M | -920.93M | -860.5M | -837.93M | -821.9M | -796.72M | -900.32M | -884.4M | -1.04B | -841.14M | -529.8M | -366.67M |
EBIT | -289.88M | -264.58M | -921.73M | -865.87M | -931.21M | -874.57M | -855.8M | -842.24M | -817.8M | -922.36M | -908.72M | -1.06B | -861.45M | -544.27M | -373.63M |
Depreciation & Amortization | 8.54M | 3.35M | 4.14M | 6.37M | 10.29M | 14.07M | 17.87M | 20.34M | 21.08M | 22.04M | 24.32M | 25.9M | 20.31M | 14.48M | 6.97M |
Add to Watchlist
Select watchlists to add or remove ROIV